Intervention effectmodel-written summary

Sap inoculation produced no symptoms in Nicotiana benthamiana by 30 days.

A claim from First report of Cistus incanus RNA virus 1 associated with Cistus monspeliensis in Greece · 2025

Intervention effectobservedoriginal resultno effectmeasured

Claim · model-written summary

Sap inoculation produced no symptoms in Nicotiana benthamiana by 30 days.

Taxon
Nicotiana benthamianaNicotiana benthamianae0
Treatment
inoculatione0
Outcome
no symptomse0
Direction
no symptomse0
Qualifier
up to 30 days post inoculatione0

Not reportedMaterialGeneCompoundOrgan / stageInteractorInteractor roleSecond interactorSecond interactor roleComparatorSettingValue

Organisms pictured · Representative pictures of the matched species, not figures from the paper.

Nicotiana benthamiana
Nicotiana benthamiana · TaxonCharles Andres · CC BY-SA 3.0 · Wikimedia Commons ↗

Verbatim

e0

“Nicotiana benthamiana, N. tabacum cv. Xanthi NC, N. rustica and Chenopodium quinoa. Plants were monitored for symptom development; however, no symptoms were recorded up to 30 days post inoculation”

✓ located verbatim in the source · abstract, characters 1884–2080

Title

First report of Cistus incanus RNA virus 1 associated with Cistus monspeliensis in Greece

D. Beris; A. Galeou; O. Kektsidou; et al. New Disease Reports 2025. doi:10.1002/ndr2.70041

Other claims from this paper (16)

Record rev-6cbf0babbc6f2e382ad89e46c5384635afb2bdf3a5e360ed1a4527f87fd540c0 · schema claims-v0.9 · position 7 in the model’s answer

inoculation · disease · Nicotiana benthamianaPositive and negative results

40 papers: 8 positive, 32 negative or no effect

31 papers in the same direction as this claim · 8 in the opposite direction

  1. positive
  2. positive
  3. positive
  4. positive
  5. positive
  6. positive
  7. positive
  8. positive

31 papers more in this group

See all 40 papers →

Claims are grouped by organism, treatment and what was measured or targeted. A paper counts as positive when any of its claims in the group is positive.